患者特征因素对肝糖代谢动力学的影响:动态全身18f -氟脱氧葡萄糖-正电子发射断层多参数成像的评价

IF 5.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Kai Tonda MD, Yu Iwabuchi MD, Tohru Shiga MD, Yoshiki Owaki RT, Arashi Fujita RT, Takehiro Nakahara MD, Ryosuke Sakurai MD, Atsushi Shimizu MD, Yoshitake Yamada MD, Masahiro Okada MD, Masahiro Jinzaki MD
{"title":"患者特征因素对肝糖代谢动力学的影响:动态全身18f -氟脱氧葡萄糖-正电子发射断层多参数成像的评价","authors":"Kai Tonda MD,&nbsp;Yu Iwabuchi MD,&nbsp;Tohru Shiga MD,&nbsp;Yoshiki Owaki RT,&nbsp;Arashi Fujita RT,&nbsp;Takehiro Nakahara MD,&nbsp;Ryosuke Sakurai MD,&nbsp;Atsushi Shimizu MD,&nbsp;Yoshitake Yamada MD,&nbsp;Masahiro Okada MD,&nbsp;Masahiro Jinzaki MD","doi":"10.1111/dom.15247","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aims</h3>\n \n <p>To assess the impact of various patient characteristics on the dynamics of liver glucose metabolism using automated multiparametric imaging with whole-body dynamic <sup>18</sup>F-fluorodeoxyglucose (FDG)-positron emission tomography (PET).</p>\n </section>\n \n <section>\n \n <h3> Materials and Methods</h3>\n \n <p>We retrospectively enrolled 540 patients who underwent whole-body dynamic FDG-PET. Three quantitative indices representing hepatic glucose metabolism [mean standardized uptake value normalized by lean body mass (SULmean), metabolic glucose rate (kinetic index) and distribution volume (DV)] were measured from multiparametric PET images produced automatically based on the Patlak plot model. Patient characteristics including age, sex, body mass index, fasting time, blood glucose level, and the presence of diabetes mellitus (DM) or hepatic steatosis (HS) were collected. We examined the correlations between the characteristic factors and three quantitative indices using multiple regression analysis.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The success rate of kinetic analysis using multiparametric PET imaging was 93.3% (504/540). Hepatic SULmean was significantly correlated with age (<i>p</i> &lt; .001), sex (<i>p</i> &lt; .001) and blood glucose level (<i>p</i> = .002). DV was significantly correlated with age (<i>p</i> = .033), sex (<i>p</i> &lt; .001), body mass index (<i>p</i> = .002), fasting time (<i>p</i> = .043) and the presence of HS (<i>p</i> = .002). The kinetic index was significantly correlated with age (<i>p</i> &lt; .001) and sex (<i>p</i> = .004). In the comparison of the healthy, DM and HS groups, patients with DM had a significantly increased SULmean, whereas patients with HS had a significantly decreased DV.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Our results showed that liver glucose metabolism was influenced by various patient characteristic factors. Multiparametric FDG-PET imaging can be used to analyse the kinetics of liver glucose metabolism in routine clinical practice.</p>\n </section>\n </div>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":"25 12","pages":"3521-3528"},"PeriodicalIF":5.4000,"publicationDate":"2023-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://dom-pubs.onlinelibrary.wiley.com/doi/epdf/10.1111/dom.15247","citationCount":"0","resultStr":"{\"title\":\"Impact of patient characteristic factors on the dynamics of liver glucose metabolism: Evaluation of multiparametric imaging with dynamic whole-body 18F-fluorodeoxyglucose-positron emission tomography\",\"authors\":\"Kai Tonda MD,&nbsp;Yu Iwabuchi MD,&nbsp;Tohru Shiga MD,&nbsp;Yoshiki Owaki RT,&nbsp;Arashi Fujita RT,&nbsp;Takehiro Nakahara MD,&nbsp;Ryosuke Sakurai MD,&nbsp;Atsushi Shimizu MD,&nbsp;Yoshitake Yamada MD,&nbsp;Masahiro Okada MD,&nbsp;Masahiro Jinzaki MD\",\"doi\":\"10.1111/dom.15247\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Aims</h3>\\n \\n <p>To assess the impact of various patient characteristics on the dynamics of liver glucose metabolism using automated multiparametric imaging with whole-body dynamic <sup>18</sup>F-fluorodeoxyglucose (FDG)-positron emission tomography (PET).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Materials and Methods</h3>\\n \\n <p>We retrospectively enrolled 540 patients who underwent whole-body dynamic FDG-PET. Three quantitative indices representing hepatic glucose metabolism [mean standardized uptake value normalized by lean body mass (SULmean), metabolic glucose rate (kinetic index) and distribution volume (DV)] were measured from multiparametric PET images produced automatically based on the Patlak plot model. Patient characteristics including age, sex, body mass index, fasting time, blood glucose level, and the presence of diabetes mellitus (DM) or hepatic steatosis (HS) were collected. We examined the correlations between the characteristic factors and three quantitative indices using multiple regression analysis.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>The success rate of kinetic analysis using multiparametric PET imaging was 93.3% (504/540). Hepatic SULmean was significantly correlated with age (<i>p</i> &lt; .001), sex (<i>p</i> &lt; .001) and blood glucose level (<i>p</i> = .002). DV was significantly correlated with age (<i>p</i> = .033), sex (<i>p</i> &lt; .001), body mass index (<i>p</i> = .002), fasting time (<i>p</i> = .043) and the presence of HS (<i>p</i> = .002). The kinetic index was significantly correlated with age (<i>p</i> &lt; .001) and sex (<i>p</i> = .004). In the comparison of the healthy, DM and HS groups, patients with DM had a significantly increased SULmean, whereas patients with HS had a significantly decreased DV.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Our results showed that liver glucose metabolism was influenced by various patient characteristic factors. Multiparametric FDG-PET imaging can be used to analyse the kinetics of liver glucose metabolism in routine clinical practice.</p>\\n </section>\\n </div>\",\"PeriodicalId\":158,\"journal\":{\"name\":\"Diabetes, Obesity & Metabolism\",\"volume\":\"25 12\",\"pages\":\"3521-3528\"},\"PeriodicalIF\":5.4000,\"publicationDate\":\"2023-08-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://dom-pubs.onlinelibrary.wiley.com/doi/epdf/10.1111/dom.15247\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes, Obesity & Metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/dom.15247\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/dom.15247","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的利用全自动多参数全身动态18f -氟脱氧葡萄糖(FDG)-正电子发射断层扫描(PET)技术评估不同患者特征对肝糖代谢动力学的影响。材料和方法我们回顾性地纳入540例接受全身动态FDG-PET治疗的患者。从基于Patlak图模型自动生成的多参数PET图像中测量代表肝脏糖代谢的三个定量指标[以瘦体重(SULmean)归一化的平均标准化摄取值(mean),代谢葡萄糖率(kinetic index)和分布体积(DV)]。收集患者的年龄、性别、体重指数、禁食时间、血糖水平、有无糖尿病(DM)或肝脂肪变性(HS)等特征。采用多元回归分析方法对特征因子与三个定量指标之间的相关性进行了检验。结果多参数PET成像动力学分析成功率为93.3%(504/540)。肝SULmean与年龄(p < .001)、性别(p < .001)、血糖水平(p = .002)显著相关。DV与年龄(p = 0.033)、性别(p < 0.001)、体重指数(p = 0.002)、禁食时间(p = 0.043)和HS的存在(p = 0.002)显著相关。动力学指数与年龄(p < .001)和性别(p = .004)显著相关。在健康组、糖尿病组和HS组的比较中,DM组患者的SULmean显著增加,而HS组患者的DV显著降低。结论肝脏糖代谢受多种患者特征因素的影响。多参数FDG-PET成像可用于分析肝脏糖代谢动力学。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Impact of patient characteristic factors on the dynamics of liver glucose metabolism: Evaluation of multiparametric imaging with dynamic whole-body 18F-fluorodeoxyglucose-positron emission tomography

Impact of patient characteristic factors on the dynamics of liver glucose metabolism: Evaluation of multiparametric imaging with dynamic whole-body 18F-fluorodeoxyglucose-positron emission tomography

Aims

To assess the impact of various patient characteristics on the dynamics of liver glucose metabolism using automated multiparametric imaging with whole-body dynamic 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET).

Materials and Methods

We retrospectively enrolled 540 patients who underwent whole-body dynamic FDG-PET. Three quantitative indices representing hepatic glucose metabolism [mean standardized uptake value normalized by lean body mass (SULmean), metabolic glucose rate (kinetic index) and distribution volume (DV)] were measured from multiparametric PET images produced automatically based on the Patlak plot model. Patient characteristics including age, sex, body mass index, fasting time, blood glucose level, and the presence of diabetes mellitus (DM) or hepatic steatosis (HS) were collected. We examined the correlations between the characteristic factors and three quantitative indices using multiple regression analysis.

Results

The success rate of kinetic analysis using multiparametric PET imaging was 93.3% (504/540). Hepatic SULmean was significantly correlated with age (p < .001), sex (p < .001) and blood glucose level (p = .002). DV was significantly correlated with age (p = .033), sex (p < .001), body mass index (p = .002), fasting time (p = .043) and the presence of HS (p = .002). The kinetic index was significantly correlated with age (p < .001) and sex (p = .004). In the comparison of the healthy, DM and HS groups, patients with DM had a significantly increased SULmean, whereas patients with HS had a significantly decreased DV.

Conclusions

Our results showed that liver glucose metabolism was influenced by various patient characteristic factors. Multiparametric FDG-PET imaging can be used to analyse the kinetics of liver glucose metabolism in routine clinical practice.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信